Physician profile
Imad Attar
NPI 1942839063
$5,361.58
in general payments reported to CMS, 2019-2025
17 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $501 · 2021: $1,586 · 2022: $588 · 2023: $1,353 · 2024: $1,096 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298 · Travel and Lodging: $1,188 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.16 |
| Travel and Lodging | $1,188.10 |
| Education | $199.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,147.03 | 2023-2025 | Prostep, Prophecy, Ortholoc 3di Crosscheck |
| Pinnacle, INC | $1,222.52 | 2021-2022 | |
| Medical Device Business Services, INC. | $1,012.96 | 2020-2023 | |
| Smith+Nephew, INC. | $179.71 | 2020-2025 | Grafix Pl, Memofix Super Elastic Nitinol Staple System |
| Integra Lifesciences Corporation | $136.84 | 2022 | |
| Organogenesis INC. | $119.70 | 2023 | Puraply Antimicrobial |
| Horizon Therapeutics Plc | $114.80 | 2022 | |
| Medtronic, INC. | $110.52 | 2022 | |
| Misonix INC | $77.57 | 2020 | |
| Paragon 28, INC. | $53.41 | 2021-2023 | Additive Orthopedics |
| Treace Medical Concepts, INC. | $40.70 | 2025 | |
| Janssen Pharmaceuticals, INC | $34.78 | 2021 | |
| Nexus Medical Technologies LLC | $28.50 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.81 | 2025 | |
| Depuy Synthes Sales INC. | $20.33 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.84 | 2025 | |
| Amgen INC. | $18.56 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imad Attar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.